Xenon Pharmaceuticals’ anti-seizure candidate has smashed a pivotal trial out of the park, lowering seizure rates by more ...

Azetukalner, a Kv7 potassium channel opener, reduced the frequency of focal onset seizures by a placebo-adjusted rate of 42.7 ...

Analysts are encouraged by azetukalner’s differentiated MoA and efficacy in epilepsy, as well as the lack of titration needed when prescribing the drug.

Researchers have discovered that mutations in the FOXJ3 gene act as a "master switch" failure, disrupting how the brain ...

A pioneering gene therapy could help treat a rare seizure disorder called Dravet syndrome, according to new clinical trial ...

A new experimental drug is showing remarkable promise for children with Dravet syndrome, a severe genetic form of epilepsy.

EpiWatch, the first FDA-cleared seizure detection app for Apple Watch, provides seizure detection, alerting and ...

Epileptic seizures alter sleep by prolonging the stage that's central to memory formation, potentially predisposing the brain ...

Many patients suffer from epilepsy that cannot be controlled by current medications. Surgical removal of epileptogenic brain regions is effective in only about half of cases, and not all patients are ...

The Wright family, from Middletown, holds National Rare Disease Day on Feb. 28 close to their hearts. Megan Wright, 35, and Ty Wright, 37, are parents to three children. Their middle child, 7-year-old ...

Many families face the challenge of drug-resistant epilepsy, questioning the transition from medication to surgery.

Join us for our annual Walk for Epilepsy Santa Barbara. The walk will be held at University of California Santa Barbara on Pauley Track. Check-in will begin at 9:30am before the walk at 10:00am. The ...